Company / Profit Margin
AYTU BIOPHARMA, INC Profit Margin History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-20.4%
FY2025
5-year range
-112.5% / -15.9%
FY2021-FY2025
Trend
+16.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -2950.3% in FY2015 to -15.9% in FY2023.
Based on SEC 10-K filings.
-20.4% in FY2025 with a 10-year CAGR of +2929.9%.
Declined from -15.9% to -20.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +92.1pp
- 5-Year Change
- +28.9pp
- 10-Year Change
- +2929.9pp
Key checks
Key Insights
- In FY2025, profit margin increased 16.0% year-over-year.
- Peak profit margin was recorded in FY2023.
- Lowest profit margin in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -20.4% | +16.0% |
| FY2024 | -24.3% | -53.1% |
| FY2023 | -15.9% | +85.9% |
| FY2022 | -112.5% | -26.7% |
| FY2021 | -88.8% | -80.2% |
| FY2020 | -49.3% | +82.3% |
| FY2018 | -278.4% | +60.2% |
| FY2017 | -698.7% | +36.5% |
| FY2016 | -1099.7% | +62.7% |
| FY2015 | -2950.3% | +72.7% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026